Literature DB >> 12902166

Putting some spine into alternative splicing.

Bernard Khoo1, Scott A Akker, Shern L Chew.   

Abstract

Spinal muscular atrophy is a neurodegenerative disease caused by mutations of the SMN1 gene. The homologous SMN2 gene is unable to complement SMN1 because of a crucial mutation in an exonic splicing enhancer, leading to alternative splicing and exclusion of exon 7. Two recent papers show that the defect in splicing of exon 7 of SMN2 is specifically corrected by small synthetic effectors. These new and specific approaches have potential in the treatment of diseases caused by defective splicing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902166     DOI: 10.1016/S0167-7799(03)00168-9

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  2 in total

1.  Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35.

Authors:  Hercules Apostolatos; André Apostolatos; Timothy Vickers; James E Watson; Shijie Song; Fernando Vale; Denise R Cooper; Juan Sanchez-Ramos; Niketa A Patel
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

Review 2.  Splicing therapeutics in SMN2 and APOB.

Authors:  Bernard Khoo; Adrian R Krainer
Journal:  Curr Opin Mol Ther       Date:  2009-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.